CAE expands healthcare simulation offering with METI buy
This article was originally published in Clinica
Executive Summary
Canadian firm CAE Healthcare, part of civil aviation and defence simulation and training specialist CAE, has acquired Medical Education Technologies Inc (METI), a developer of medical simulation technology, for $130m. The deal will make CAE a leader in the healthcare simulation segment, and expand its global footprint and product offering. As well as its headquarters in Sarasota, Florida, METI has facilities in Hungary and Germany. It reports revenues of over $60m per year. The company's CEO Michael Bernstein will take on the role of president of the merged CAE Healthcare. CAE expects the deal to boost its core market segment, which includes healthcare and mining. It predicts the unit will achieve revenues of $120m and be profitable by fiscal 2013. CAE has issued $150m of senior notes in a private placement to fund the acquisition.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.